Logotype for Industrie De Nora S.p.A.

Industrie De Nora (DNR) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Industrie De Nora S.p.A.

Q3 2024 earnings summary

16 Jan, 2026

Executive summary

  • 9M 2024 revenues reached €601.2 million, with adjusted EBITDA margin at 17.8%, both in line with guidance despite a soft Q3; Q4 is expected to drive full-year recovery.

  • Net income for 9M 2024 was €52.5 million, representing 8.7% of revenues, with a net cash position of €29.7 million and €81 million operating cash flow generated.

  • Backlog increased by over 10% year-to-date, driven by strong order intake in Water Technologies and continued growth in Energy Transition projects.

  • Strategic investments in manufacturing capacity, including the Italian Gigafactory and expansion in Germany and Asia, support long-term growth.

  • ESG initiatives advanced, with progress on sustainability targets, gender equality, and clean energy, and notable recognitions.

Financial highlights

  • Revenues for 9M 2024 were €601.2 million, down 4.5% year-over-year, mainly due to FX impacts; at constant FX, revenues were €614.7 million.

  • Adjusted EBITDA for 9M 2024 was €107.3 million (17.8% margin), down from €122.0 million (19.4%) in 9M 2023.

  • Net income for 9M 2024 was €52.5 million, compared to €198.6 million in 9M 2023, which included a €133 million non-recurring gain from TK nucera's IPO.

  • Net cash position at September 2024 was €29.7 million, with strong operating cash flow more than covering capex and dividends.

  • Operating cash flow exceeded €80 million in the first nine months.

Outlook and guidance

  • Full-year 2024 guidance confirmed: low single-digit group revenue growth, with Water Technologies and Energy Transition expected to grow and Electrode Technologies to remain broadly flat.

  • Adjusted EBITDA margin for the year expected at around 17%.

  • Q4 revenues are secured in the backlog and expected to drive a strong finish to the year.

  • Recovery in Electrode Technologies orders anticipated in Q4 and into 2025, especially in Chlor Alkali and Electronics markets.

  • CapEx plan is under review and will be updated in March 2025, with flexibility to adjust investment intensity based on hydrogen demand.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more